OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Hematology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Clonal hematopoiesis in unexplained cytopenias	441
Deciphering clonal architecture and evolutionary dynamics of secondary acute myeloid leukemia and donor‐derived myelodysplastic syndrome using single‐cell multi‐omics analysis	252
	211
The latest insights into rare blood disorders: Diagnosis and treatment strategies	152
Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia	146
Complete response to pembrolizumab and radiation in a patient with HIV‐negative, EBV‐positive plasmablastic lymphoma	142
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data	135
Issue Information	133
NPM1‐mutated myeloid neoplasm with low percentage of blasts	128
Improving healthspan among people with sickle cell disease: Leveraging precision health in an era of treatments with curative intent	121
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations	106
Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients	92
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?	83
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis	78
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives	75
A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia	75
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis	69
Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era	68
Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletion	67
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors	65
How the United States syphilis epidemic may portend a resurgence of an unusual hematologic condition: The connection between syphilis and paroxysmal cold hemoglobinuria	64
Characteristics and prevalence of antibiotic allergies in patients with sickle cell disease: A single‐center retrospective study	62
Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease	62
Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin‐6 values in endotracheal and pleural fluids	59
	59

Breast implant‐associated anaplastic large cell lymphoma	56
Multi‐organ dysfunction secondary to abrupt discontinuation of voxelotor in a patient with severe sickle cell disease	56
Oligoclonal gamma‐delta T cell expansion in response to Ehrlichia infection	56
A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia	55
An unusual lymphoma involving the GI tract and bone marrow	55
Acute thrombocytopenia suggesting thrombotic microangiopathy	55
Hemolysis after high‐dose intravenous immunoglobulin: An under‐appreciated sequelae	53
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome	52
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications	48
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes fr	47
Clinically meaningful improvements in patient‐reported outcomes in mitapivat‐treated patients with pyruvate kinase deficiency	46
Issue Information	45
Novel germline JAK2^R715T mutation causing PV‐like erythrocytosis in 3 generations. Amelioration by Ropeg‐Interferon	45
Rainer Prohaska (1943–2022)	44
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?	44
Clinical impact of cytomorphology in mast cell leukemia	44
Sickle cell allele HBB‐rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africa	43
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma	42
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies	42